Deals
Fujifilm Shifts Focus to Stem Cells and Ebola Drugs
This article is for subscribers only.
During a recent magazine shoot in Japan, Fujifilm Holdings Corp.’s Chairman Shigetaka Komori posed in a white lab coat, wielding a test tube in his hand.
Komori is no scientist, but the image embodies the Japanese brand’s shift away from photo-film and to new science and technology markets: Ebola drugs, anti-aging lotions and stem cell research.